# Seda Pharma Development Services Ltd

## Details

- **Company number:** [09442533](https://find-and-update.company-information.service.gov.uk/company/09442533)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 17 Feb 2015
- **Registered office:** UNIT 4 OAKFIELD ROAD CHEADLE ROYAL BUSINESS PARK, CHEADLE, STOCKPORT, SK8 3GX
- **Nature of business:** [72190](/sic/72190) Other research and experimental development on natural sciences and engineering
- **Corporate group:** [GMV Nominees Ltd](/group/4) (48216 companies)




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Aleva Holdings Limited | voting-rights-25-to-50-percent | 24 Apr 2019 | 3 Mar 2026 |
| Mr Paul William Stott | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 3 Jan 2026 | 16 Mar 2026 |
| Mr Paul Alfred Dickinson | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 16 Mar 2026 |
| Mr Marcel De Matas | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 16 Mar 2026 |
| Bgf Nominees Limited | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 16 Mar 2026 |  |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2025 | £4,369,206 | £518,968 | 0 |
| 31 Mar 2024 | £3,379,917 | £1,786,428 | 28 |
| 31 Mar 2023 | £2,612,959 | £781,392 | 22 |
| 31 Mar 2022 | £2,037,397 | £777,550 | 16 |
| 31 Mar 2021 | £995,900 | £731,602 | 10 |
| 31 Mar 2020 | £579,176 | £547,501 | 6 |
| 31 Mar 2019 | £483,717 | - | 5 |
| 31 Mar 2018 | £279,761 | - | - |



## Owned by

Seda Pharma Development Services Ltd → [BGF Nominees Limited](/company/10007355) → [BGF Group PLC](/company/10657226) → [Barclays Funds Investments Limited](/company/04002470) → [Barclays Equity Holdings Limited](/company/02569002) → [Barclays Principal Investments Limited](/company/08116604)